206 related articles for article (PubMed ID: 10754776)
1. Inotropes in the beta-blocker era.
Lowes BD; Simon MA; Tsvetkova TO; Bristow MR
Clin Cardiol; 2000 Mar; 23(3 Suppl):III11-6. PubMed ID: 10754776
[TBL] [Abstract][Full Text] [Related]
2. Inotropes and beta-blockers: is there a need for new guidelines?
Bristow MR; Shakar SF; Linseman JV; Lowes BD
J Card Fail; 2001 Jun; 7(2 Suppl 1):8-12. PubMed ID: 11605160
[TBL] [Abstract][Full Text] [Related]
3. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
[TBL] [Abstract][Full Text] [Related]
4. Combined oral positive inotropic and beta-blocker therapy for treatment of refractory class IV heart failure.
Shakar SF; Abraham WT; Gilbert EM; Robertson AD; Lowes BD; Zisman LS; Ferguson DA; Bristow MR
J Am Coll Cardiol; 1998 May; 31(6):1336-40. PubMed ID: 9581729
[TBL] [Abstract][Full Text] [Related]
5. Improvement of postreceptor events by metoprolol treatment in patients with chronic heart failure.
Böhm M; Deutsch HJ; Hartmann D; Rosée KL; Stäblein A
J Am Coll Cardiol; 1997 Oct; 30(4):992-6. PubMed ID: 9316529
[TBL] [Abstract][Full Text] [Related]
6. Beta blocker therapy, decompensated heart failure, and inotropic interactions: current perspectives.
Zafrir B; Amir O
Isr Med Assoc J; 2012 Mar; 14(3):184-9. PubMed ID: 22675861
[TBL] [Abstract][Full Text] [Related]
7. Role of nonglycosidic inotropic agents: indications, ethics, and limitations.
Chatterjee K; De Marco T
Med Clin North Am; 2003 Mar; 87(2):391-418. PubMed ID: 12693731
[TBL] [Abstract][Full Text] [Related]
8. [Role of the enoximone-dobutamine combination in the treatment of congestive cardiac insufficiency].
Richard C; Thuillez C; Annane D; Bellissant E; Teboul JL
Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():33-7. PubMed ID: 2147832
[TBL] [Abstract][Full Text] [Related]
9. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs.
Sidi A; Muehlschlegel JD; Kirby DS; Lobato EB
Br J Anaesth; 2006 Dec; 97(6):799-807. PubMed ID: 17035336
[TBL] [Abstract][Full Text] [Related]
10. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
11. [Mechanism of the positive inotropic effect of phosphodiesterase inhibitors].
Scholz H; Dieterich HA; Schmitz W
Z Kardiol; 1991; 80 Suppl 4():1-6. PubMed ID: 1656618
[TBL] [Abstract][Full Text] [Related]
12. General overview and update of positive inotropic therapy.
Leier CV
Am J Med; 1986 Oct; 81(4C):40-5. PubMed ID: 2946223
[TBL] [Abstract][Full Text] [Related]
13. [New inotropic agents in the treatment of congestive heart failure].
Freitas M
Rev Port Cardiol; 1993 Nov; 12 Suppl 4():19-28, 7-8. PubMed ID: 7904458
[TBL] [Abstract][Full Text] [Related]
14. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
15. Enoximone echocardiography: a novel test to evaluate left ventricular contractile reserve in patients with heart failure on chronic beta-blocker therapy.
Ghio S; Constantin C; Raineri C; Fontana A; Klersy C; Campana C; Tavazzi L
Cardiovasc Ultrasound; 2003 Sep; 1():13. PubMed ID: 14596683
[TBL] [Abstract][Full Text] [Related]
16. Comparative effects on hemodynamics of enoximone (MDL 17,043), dobutamine and nitroprusside in severe congestive heart failure.
Installé E; Gonzalez M; Jacquemart JL; Collard P; Roulette F; Pourbaix S; Tremouroux J
Am J Cardiol; 1987 Aug; 60(5):46C-52C. PubMed ID: 2956868
[TBL] [Abstract][Full Text] [Related]
17. Low-level inotropic stimulation with type III phosphodiesterase inhibitors in patients with advanced symptomatic chronic heart failure receiving beta-blocking agents.
Shakar SF; Bristow MR
Curr Cardiol Rep; 2001 May; 3(3):224-31. PubMed ID: 11305977
[TBL] [Abstract][Full Text] [Related]
18. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol.
Lowes BD; Tsvetkova T; Eichhorn EJ; Gilbert EM; Bristow MR
Int J Cardiol; 2001 Dec; 81(2-3):141-9. PubMed ID: 11744130
[TBL] [Abstract][Full Text] [Related]
19. Why beta blockers should be used in heart failure.
Bhagat K; Hakim JG
Cent Afr J Med; 1999 Jul; 45(7):187-9. PubMed ID: 10695198
[TBL] [Abstract][Full Text] [Related]
20. Some new positive inotropic agents.
Andersson KE
Acta Med Scand Suppl; 1986; 707():65-73. PubMed ID: 2874692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
